These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12001816)

  • 1. Influenza virus vaccine live intranasal--Aviron. Flumist, influenza vaccine live intranasal.
    Drugs R D; 2002; 3(2):123-9. PubMed ID: 12001816
    [No Abstract]   [Full Text] [Related]  

  • 2. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza virus vaccine live intranasal (Aviron). FluMist, influenza vaccine live intranasal.
    Drugs R D; 1999 Sep; 2(3):204-7. PubMed ID: 10641229
    [No Abstract]   [Full Text] [Related]  

  • 4. Technology evaluation: FluMist, University of Michigan.
    Billich A
    Curr Opin Mol Ther; 2000 Jun; 2(3):340-4. PubMed ID: 11249630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demystifying FluMist, a new intranasal, live influenza vaccine.
    Mossad SB
    Cleve Clin J Med; 2003 Sep; 70(9):801-6. PubMed ID: 14518575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FluMist: an intranasal live influenza vaccine.
    Med Lett Drugs Ther; 2003 Aug; 45(1163):65-6. PubMed ID: 12915803
    [No Abstract]   [Full Text] [Related]  

  • 7. Intranasal live attenuated seasonal influenza vaccine: does not challenge current practice.
    Prescrire Int; 2013 Sep; 22(141):201-4. PubMed ID: 24171209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of peroral and intranasal immunization of school children with live allantoic influenza vaccine- and comparative study.
    Koval TA; Aleksandrova GI; Grunis AM; Ivannikov YuG ; Medvedeva TE; Sychev SV; Shaposhnikova RP; Smorodintsev AA
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(2):194-200. PubMed ID: 395255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal flu vaccine available this season.
    Piascik P
    J Am Pharm Assoc (2003); 2003; 43(6):728-30. PubMed ID: 14717271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trivalent intranasal influenza vaccine, live.
    McCarthy MW; Kockler DR
    Ann Pharmacother; 2004 Dec; 38(12):2086-93. PubMed ID: 15494383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteosome-adjuvanted intranasal influenza vaccines: advantages, progress and future considerations.
    Burt D; Mallett C; Plante M; Zimmermann J; Torossian K; Fries L
    Expert Rev Vaccines; 2011 Mar; 10(3):365-75. PubMed ID: 21434804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live attenuated intranasal influenza vaccine.
    Belshe RB; Couch RB; Glezen WP; Treanor JT
    Vaccine; 2002 Oct; 20(29-30):3429-30. PubMed ID: 12297386
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and effectiveness of live attenuated influenza vaccine in school-age children.
    Coelingh K; Olajide IR; MacDonald P; Yogev R
    Expert Rev Vaccines; 2015; 14(10):1331-46. PubMed ID: 26372891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal Administration of Whole Inactivated Influenza Virus Vaccine as a Promising Influenza Vaccine Candidate.
    Ainai A; Suzuki T; Tamura SI; Hasegawa H
    Viral Immunol; 2017; 30(6):451-462. PubMed ID: 28650274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of live attenuated influenza virus vaccine in the US.
    Belshe RB
    Virus Res; 2004 Jul; 103(1-2):177-85. PubMed ID: 15163507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of influenza antigen with rapid antibody-based tests after intranasal influenza vaccination (FluMist).
    Ali T; Scott N; Kallas W; Halliwell ME; Savino C; Rosenberg E; Ferraro M; Hohmann E
    Clin Infect Dis; 2004 Mar; 38(5):760-2. PubMed ID: 14986264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal influenza vaccine enters Phase I clinical trial.
    Expert Rev Vaccines; 2007 Jun; 6(3):305. PubMed ID: 17542745
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer.
    Halasa N; Englund JA; Nachman S; Weinberg GA; Huber VC; Allison K; Dubovsky F; Yi T; McCullers JA; Flynn PM
    Vaccine; 2011 May; 29(24):4110-5. PubMed ID: 21496468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
    Belshe RB; Mendelman PM; Treanor J; King J; Gruber WC; Piedra P; Bernstein DI; Hayden FG; Kotloff K; Zangwill K; Iacuzio D; Wolff M
    N Engl J Med; 1998 May; 338(20):1405-12. PubMed ID: 9580647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promises and challenges of live-attenuated intranasal influenza vaccines across the age spectrum: a review.
    Boyce TG; Poland GA
    Biomed Pharmacother; 2000 May; 54(4):210-8. PubMed ID: 10872719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.